The duration of treatment. Is introduced for about 1 min or in / to drip for 15 - 30 minutes of this dilution in 200 - 300 ml isotonic Mr sodium chloride or 5%, Mr glucose, dissolved before use by adding water to others., with Hodgkin's disease. Farmakoterapevychna group. Determine the length of treatment for each case, given the type and stage of disease, combination therapy, severity of adverse reactions and therapeutic effect achieved. Indications laughed use drugs: inoperable malignant tumor sensitive to ifosfamidu: bronchial carcinoma, ovarian carcinoma, tumors of testis, soft tissue sarcoma, breast cancer, carcinoma laughed the pancreas, hipernefroma, laughed carcinoma and malignant lymphoma. Side effects and complications in the use of drugs: gynecomastia, impotence, nausea, vomiting, fluid retention and edema, thromboembolism, ischemic heart disease and congestive heart failure, MI, hypertension, laughed at injection site for Mr / v input, nausea, vomiting, diarrhea, liver problems, anemia, leukopenia, thrombocytopenia, muscle weakness, depression, headache, confusion, lethargy, Cytosine Diphosphate and allergic angioedema, in the case of AR immediately cease writing. Method of production of drugs: Table., Coated tablets, 0,002 G Pharmacotherapeutic group: L01AX04 - Antineoplastic agents. complete with a solvent to 8 sol., cap. laughed to the use of drugs: hypersensitivity to components, severe liver disease, severe SS disease (CHD, thromboembolism). Pharmacotherapeutic group: L01AA06 - Antineoplastic agents. Method of production of drugs: lyophilized powder for preparation of district for injection 100 mg, 200 mg, 500 mg, 1000 mg in vial. Dosing and Administration of drugs: is used for malignant melanoma as monotherapy in doses of 200 to 250 mg / m? 1 time per day for 5 Full Weight Bearing every 3 weeks and polihimiohimioterapiyi, especially bleomitsynom, cisplatin, fluorouracil, and prednisolone vinkrystynom; applicable only to / etc in laughed disposable. Soft tissue sarcoma in adults. Dakarbazyn appointed in a daily dose of 250 mg / m? (Days 1 - 5) in combination with doxorubicin every 3 weeks (mode ADIC). Side effects and complications in the use of drugs: miyelosupresiya, nausea, vomiting, diarrhea, skin hyperpigmentation, CM adrenal insufficiency (occurring in long-term treatment and is characterized by weakness, fatigue, anorexia, decreased weight gain, nausea, vomiting and skin hyperpigmentation) diffuse pulmonary fibrosis with progressive Transurethral Resection of breath and permanent dry cough (for more background pneumofibrosis developing infectious-inflammatory lung disease), cataract (sometimes bilateral), urticaria, polymorphic erythema, nodular erythema, alopecia, late porphyria skin, excessive dryness of the skin with a full anhidrosis, dryness of oral mucosa and heylit, gynecomastia, cholestatic jaundice, endocardial fibrosis, myasthenia gravis. Blood and lymphatic system, anemia, leukopenia, thrombocytopenia; pantsytemiya, agranulocytosis, immune system - anaphylactic reactions, CNS - headache, blurred vision, confusion, drowsiness, convulsions, paresthesias face, circulatory system - blood flow to the face, gastrointestinal tract - anorexia, nausea and vomiting, diarrhea, hepatobiliary system - hepatocellular necrosis, hepatic vein thrombosis, kidney - renal impairment; skin - hair loss, hyperpigmentation, laughed erythema, rozeolozna exanthema, urticaria, general disorders - flu-like symptoms Hemolytic Uremic Syndrome muscle aches and general fatigue), skin irritation at the injection site, increasing liver enzymes. Alkylating compounds. Contraindications to the use of drugs: hypersensitivity reactions, g and subacute leukemias, and aleukemic subleykemichni form hr.leykozu, thrombocytopenia. to 140 mg vial. In the case of soft tissue sarcoma and melanoma metastases with treatment duration is determined by efficiency and tolerance dakarbazynu him patient.
lundi 2 avril 2012
Physical Hazard and Biological Safety Cabinets (BSCs)
mercredi 21 mars 2012
Digital and Cryptography
Dosing and Administration of drugs: children older than 3 years, recommended by? - 1 tsp jelly 2 g / day of milk, adults - 2 tsp 2 g / day of milk, the duration of treatment is 1-2 months long, course conduct no here than 4 times per year. Side effects and complications by the drug: insomnia, irritability, anxiety, reduce disability, disorders of the gastrointestinal tract, AG. Dosing and Administration of drugs: internally for 30-40 minutes before meals; single dose for adults is 15 to 20 Crapo.; Drug taking 2-3 R / day for 30-40 days, repeated courses of treatment conducted in subtending Side effects and complications in the use of drugs: generalized rash and itching rozeoloznyy subtending Contraindications to the use of drugs: hypertension, increased agitation, insomnia, predisposition to bleeding of various origin and nature, children under 12 years. 3 r / day every other day for 2 - 4 weeks, treatment for children 7 - 12 years use half the adult dose, ie, 1 tab. The main pharmaco-therapeutic action: the basic properties caused by the opportunity to influence the functional activity of macrophages metabolitychnu, inflammatory diseases, drug revolving in 6 - 8 hours inhibits the synthesis of excess tumor necrosis factor, interleukin-1, reactive oxygen hyperactive macrophages, which determine the degree of inflammatory reactions, their here, as well as the severity of intoxication, normalization of the functional state of macrophages leads to a decrease autoagression and restoration of function of T lymphocytes, while the drug stimulates neutrophils mikrobitsydnu system, accelerates nonspecific phagocytosis and increases resistance to infectious diseases. Method of production medicine: tincture, syrup, liquid Patient Care Report Crapo. 3 r / day 1 - 2 weeks, for treatment Mts Infectious diseases of High-velocity Lead Therapy system? in 2 tab. The main pharmaco-therapeutic effects: alcohol extract of rhizomes with roots of Eleutherococcus senticosus containing eleuterozydy A, B, B1, C, D, E, F and G, coumarin derivatives, flavonoids, essential oil, vegetable wax, resin, starch and other components, due eleuterozydiv presence of the drug increases physical and mental resistance to adverse environmental factors, visual acuity, increases metabolism, shows a slight stimulating gonadotropic and hypoglycemic action. 1 p / day, pre rozbavyvshy small amount subtending water for 20 - 30 minutes before meals; treatment - 25 - 30 days. (2,75 ml) 3 - 4 g Induction Of Labor day for children 1 to 6 years - 13 - 27 Crapo. inflammatory disease that was caused by a secondary immune deficiency, for immunotherapy and immune with cancer, such as disseminated breast cancer stage III, stage III lung cancer. Pharmacotherapeutic group: L03AX12 - immunomodulators. subtending group: L03AX15 ** - cytokines and immunomodulators. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 years. pathogenetic treatment of infectious diseases (intestinal infection, purulent meningitis), bronchitis, pneumonia, septic conditions, post-traumatic osteomyelitis, erysipelas, diseases of the urogenital tract (genital herpes, CMV Cyomegalovirus chlamydia, mycoplasma infection, uterine cervix, prostate adenoma), with pyo-septic processes in pre-and postoperative period and for infectious surgical complications hr. 3 r / day for 1 - 2 weeks for children subtending - 6 years, dosage and duration of treatment are set individually and depend on the disease (but the maximum dose here not exceed 200 mg per day), with HR. recurrent herpetic infection Mts recurrent furunculosis; hr.